Clinical Trial Update: Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic comparison study of CHF1535 NEXT DPI versus CHF1535 pMDI in asthma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CHF1535 NEXT DPI
• CHF1535 pMDI

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED